All articles by Sanjay Kumar – Page 3
-
BusinessDaiichi Sankyo awarded damages from former Ranbaxy owners
Arbitration says Singh family withheld information about regulatory investigations during Ranbaxy takeover
-
BusinessIndian pharma under increased regulatory scrutiny
Import bans and tightened rules pose a significant challenge for companies
-
Business
Sun Pharma snares Ranbaxy in $4bn deal
Acquisition makes Sun biggest drug firm in India and fifth largest generics producer in the world
-
NewsScientists left unimpressed by Indian budget
7.5% funding boost for science and technology fails to offset cuts of more than 20% last year
-
FeatureIndia’s chemistry challenges
India’s climate, its vast population and extremely rapid development make it host to a unique set of challenges. Sanjay Kumar finds out how Indian chemists are developing home-grown solutions
- Previous Page
- Page1
- Page2
- Page3
- Next Page